title: Apoptosis and nestin expression in the cortex and cultured astrocytes following 6-OHDA administration.
abstract: We used the dopaminergic neurotoxicant, 6-hydroxydopamine (6-OHDA), as a tool to characterize the origins of the astrocytic response to injury. Reactive astrocytes were examined by immunocyto- and histo-chemical visualization of nestin protein in the brain and cultivated cells. Following 6-OHDA (dose-dependent) treatment, the expression of nestin-like immunoreactive cells in the corpus callosum and cerebral cortex was increased compared with that of the control animals, indicating that a significant up-regulation of nestin protein occurred in these regions. In the corpus callosum and cerebral cortex, the majority of the nestin-like immunoreactive cells showed a distribution and pattern similar to those of the glial fibrillary acid protein (GFAP)-immunoreactive cells. Double immunofluorescence measurements showed that 100% of the nestin-like immunoreactive cells expressed GFAP-immunoreactive cells, indicating that these nestin-like immunoreactive cells belong to a reactive population of the astrocytes. In this study, we observed the morphological changes in the astrocytes following 6-OHDA administration, demonstrating that 6-OHDA induced injury leads to a rapid and transient up-regulation of nestin-like immunoreactivity in activated astrocytes.
authors.affiliation: Department of Neurosurgery, Gachon Medical College, Gil Medical Center, 1198 Kuwel-Dong, Incheon 405-220, South Korea. neurobeauty@hanmail.net
authors.forename: Young Mi
authors.initials: YM
authors.lastname: Yoo
authors.forename: Uhn
authors.initials: U
authors.lastname: Lee
authors.forename: Yong Jung
authors.initials: YJ
authors.lastname: Kim
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis / Q000187:drug effects*; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D005904:Glial Fibrillary Acidic Protein / Q000096:biosynthesis / Q000235:genetics; D020287:In Situ Nick-End Labeling; D007267:Injections; D007381:Intermediate Filament Proteins / Q000096:biosynthesis*; D017072:Neostriatum; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D064231:Nestin; D016627:Oxidopamine / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000166:cytology / Q000187:drug effects; D013565:Sympatholytics / Q000633:toxicity*
chemical_list: D005904:Glial Fibrillary Acidic Protein; D007381:Intermediate Filament Proteins; D009419:Nerve Tissue Proteins; C577486:Nes protein, rat; D064231:Nestin; D013565:Sympatholytics; D016627:Oxidopamine